April 4, 2022 Press Releases AMR Action Fund Announces First Investments in Adaptive Phage Therapeutics and Venatorx Pharmaceuticals Read More +
January 21, 2022 In the News A timely reality check on silent pandemic of antimicrobial resistance Read More +
November 18, 2021 In the News Pressure grows for market reforms to help tackle ‘silent pandemic’ of AMR Read More +
November 10, 2021 In the News More Investment Sorely Needed to Combat Antimicrobial Resistance Read More +
July 15, 2021 Press Releases The AMR Action Fund Appoints John H. Rex, MD as Chair of its Scientific Advisory Board Read More +
